To date, similarly to SARS-CoV, people infected with SARS-CoV-2 are reported usually to develop IgA and IgM antibodies 7–14 days after symptoms develop and, together with later IgGs, antibodies are present before the resolution of infection (Figure 1) (49). The gene discussed is CD40LG; the disease is infection.